{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:40:27Z","timestamp":1761054027746,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.anai.2013.12.019","type":"journal-article","created":{"date-parts":[[2014,1,14]],"date-time":"2014-01-14T09:16:57Z","timestamp":1389691017000},"page":"262-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Lymphopenia induced by etanercept"],"prefix":"10.1016","volume":"112","author":[{"given":"Amber N.","family":"Pepper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neetu","family":"Talreja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory M.","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark C.","family":"Glaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard F.","family":"Lockey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/j.anai.2013.12.019_bib1","first-page":"i33","article-title":"Incidence of cytopaenias with anti-TNF therapy","volume":"46","author":"Yazdani","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.anai.2013.12.019_bib2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/rheumatology\/kem332","article-title":"Three significant cases of neutropenia with etanercept","volume":"47","author":"Wenham","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.anai.2013.12.019_bib3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1590\/S0482-50042012000100011","article-title":"Leukopenia and thrombocytopenia induced by etanercept: two case reports and literature review","volume":"52","author":"Azevedo","year":"2012","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.anai.2013.12.019_bib4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/RHU.0b013e318231fd99","article-title":"Successful use of tocilizumab in a patient with rheumatoid arthritis following severe pancytopenia during etanercept therapy","volume":"17","author":"Szalay","year":"2011","journal-title":"J\u00a0Clin Rheumatol"},{"key":"10.1016\/j.anai.2013.12.019_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10067-011-1822-2","article-title":"Re-challenge with etanercept in patients with etanercept-induced neutropenia","volume":"31","author":"Haroon","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.anai.2013.12.019_bib6","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/acr.20037","article-title":"Neutropenia in patients receiving anti-tumor necrosis factor therapy","volume":"62","author":"Hastings","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.anai.2013.12.019_bib7","first-page":"234","article-title":"Peripheral blood lymphocytes from patients with rheumatoid arthritis are differentially sensitive to apoptosis induced by anti-tumour necrosis factor-alpha therapy","volume":"26","author":"Coury","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.anai.2013.12.019_bib8","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1093\/rheumatology\/keq249a","article-title":"BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies","volume":"49","author":"Ding","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.anai.2013.12.019_bib9","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.23721","article-title":"American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis","volume":"59","author":"Saag","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.anai.2013.12.019_bib10","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/acr.21641","article-title":"2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis","volume":"64","author":"Singh","year":"2012","journal-title":"Arthritis Care Res"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120613009496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120613009496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:10:03Z","timestamp":1761052203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120613009496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S1081120613009496"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2013.12.019","relation":{},"ISSN":["1081-1206"],"issn-type":[{"type":"print","value":"1081-1206"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphopenia induced by etanercept","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2013.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}